Matteo Zignol
Matteo Zignol
Unit Head, Global Tuberculosis Programme, World Health Organization
Verified email at
Cited by
Cited by
World Health Statistics 2016 [OP]: Monitoring Health for the Sustainable Development Goals (SDGs)
World Health Organization
World Health Organization, 2016
Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis
NR Gandhi, P Nunn, K Dheda, HS Schaaf, M Zignol, D Van Soolingen, ...
The Lancet 375 (9728), 1830-1843, 2010
Global incidence of multidrug-resistant tuberculosis
M Zignol, MS Hosseini, A Wright, CL Weezenbeek, P Nunn, CJ Watt, ...
The Journal of infectious diseases 194 (4), 479-485, 2006
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
D Falzon, E Jaramillo, HJ Schünemann, M Arentz, M Bauer, J Bayona, ...
European Respiratory Journal 38 (3), 516-528, 2011
Epidemiology of antituberculosis drug resistance 2002–07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance
A Wright, M Zignol, A Van Deun, D Falzon, SR Gerdes, K Feldman, ...
The Lancet 373 (9678), 1861-1873, 2009
The WHO policy package to combat antimicrobial resistance
E Leung, DE Weil, M Raviglione, H Nakatani
Bulletin of the World Health Organization 89, 390-392, 2011
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
N Ahmad, SD Ahuja, OW Akkerman, JWC Alffenaar, LF Anderson, ...
The Lancet 392 (10150), 821-834, 2018
A postgenomic method for predicting essential genes at subsaturation levels of mutagenesis: application to Mycobacterium tuberculosis
G Lamichhane, M Zignol, NJ Blades, DE Geiman, A Dougherty, J Grosset, ...
Proceedings of the National Academy of Sciences 100 (12), 7213-7218, 2003
Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010
M Zignol, W Gemert, D Falzon, C Sismanidis, P Glaziou, K Floyd, ...
Bulletin of the world Health Organization 90, 111-119, 2012
Drug-resistant tuberculosis: time for visionary political leadership
I Abubakar, M Zignol, D Falzon, M Raviglione, L Ditiu, S Masham, I Adetifa, ...
The Lancet infectious diseases 13 (6), 529-539, 2013
Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF
K Weyer, F Mirzayev, GB Migliori, W Van Gemert, L D'Ambrosio, M Zignol, ...
European Respiratory Journal 42 (1), 252-271, 2013
A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis
P Miotto, B Tessema, E Tagliani, L Chindelevitch, AM Starks, C Emerson, ...
European Respiratory Journal 50 (6), 2017
Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues
CJ Meehan, GA Goig, TA Kohl, L Verboven, A Dippenaar, M Ezewudo, ...
NATURE reviews microbiology 17 (9), 533-545, 2019
Policy guidance on drug-susceptibility testing (DST) of second-line antituberculosis drugs
World Health Organization
World Health Organization, 2008
Multidrug-resistant tuberculosis in Belarus: the size of the problem and associated risk factors
A Skrahina, H Hurevich, A Zalutskaya, E Sahalchyk, A Astrauko, S Hoffner, ...
Bulletin of the World Health Organization 91, 36-45, 2013
Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk
A Skrahina, H Hurevich, A Zalutskaya, E Sahalchyk, A Astrauko, ...
European Respiratory Journal 39 (6), 1425-1431, 2012
World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update
F Mirzayev, K Viney, NN Linh, L Gonzalez-Angulo, M Gegia, E Jaramillo, ...
European Respiratory Journal 57 (6), 2021
Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project
M Zignol, AS Dean, N Alikhanova, S Andres, AM Cabibbe, DM Cirillo, ...
The Lancet infectious diseases 16 (10), 1185-1192, 2016
National tuberculosis prevalence surveys in Asia, 1990–2012: an overview of results and lessons learned
I Onozaki, I Law, C Sismanidis, M Zignol, P Glaziou, K Floyd
Tropical Medicine & International Health 20 (9), 1128-1145, 2015
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report
S Borisov, E Danila, A Maryandyshev, M Dalcolmo, S Miliauskas, L Kuksa, ...
European Respiratory Journal 54 (6), 2019
The system can't perform the operation now. Try again later.
Articles 1–20